FirmaIQ
Org.nr 990 646 066 AS · OSLO · 72.100 Forskning og eksperimentell utvikling innenfor naturvitenskap og teknikk Gaustadalléen 21, 0349 OSLO Latest filing: Årsregnskap 2025 · approved 13.05.2026 · journal 2026 705017 Analysis generated: 09 Sep 2026 · Auto-onboard

NYKODE THERAPEUTICS ASA

NYKODE THERAPEUTICS ASA · 20 published annual accounts (2006–2025). Latest year revenue 453.0k NOK, net result -12.7m NOK, equity 95.0m NOK, cash 59.3m NOK. Figures from Brønnøysund årsregnskapskopi / nøkkeltall.

Auto summary · grounded in R2006–R2025
Reported fact Calculated Interpretation Unknown

Smart Search OSINT dossier

Simple version

Explain it like I’m ten

Numbers from the 2025 accounts. [R2025]

How much they sold
About 453.0k

Operating income / revenue in 2025.

Did they make money?
-12.7m

Net result for 2025.

What’s left in the company
Equity 95.0m

Book equity at year-end.

Cash
59.3m

Bank deposits and cash (when disclosed).

At a glance · 2025

Key figures

Revenue / sales
453 000
NOK · [R2025]
Net result
-12 673 000
NOK · [R2025]
Equity
94 977 000
NOK · [R2025]
Cash
59 271 000
NOK · [R2025]
Total assets
102 717 000
NOK · [R2025]
Paid-in equity
112 612 000
NOK · [R2025]

Trends

20-year arc

Charts use figures extracted from published annual reports.

Sales / revenue

Equity & cash

Cost / investment lines

Salary costs (lønnskostnader)

FTEs (årsverk)

From notes when disclosed; blank years mean not found in OCR.